THC BioMed Intl Ltd. announced that it has appointed Don Shaxon to the company's newly formed Advisory Board. Mr. Shaxon brings 20 years' experience in the capital markets including a successful position as Corporate development Manager with Cannabis Science Inc. where he was instrumental in helping build the company from a small cap company into an industry leader with a market cap that topped $100 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | -.--% |
|
-.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.4M | |
+26.93% | 5.55B | |
-33.55% | 3.52B | |
-3.74% | 3.03B | |
-26.09% | 2.59B | |
-10.93% | 2.28B | |
+41.50% | 1.88B | |
+41.84% | 1.46B | |
+47.62% | 1.42B | |
-28.07% | 1.26B |
- Stock Market
- Equities
- THC Stock
- News THC Biomed Intl Ltd.
- THC BioMed Intl Ltd. Appoints Don Shaxon to its Advisory Board